Publications by authors named "Francesca Valcamonico"

Claim this Profile
T
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study.
Martina Buffoni, Alberto Dalla Volta, Francesca Valcamonico, Marco Bergamini, Irene Caramella

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial.
Alberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, Giuseppe Procopio, Pierangela Sepe

Prostate Cancer Prostatic Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide.
Alberto Dalla Volta, Francesca Valcamonico, Andrea Zivi, Giuseppe Procopio, Pierangela Sepe

Eur Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Marco Bergamini, Alberto Dalla Volta, Carlotta Palumbo, Stefania Zamboni, Luca Triggiani, Francesca Valcamonico

Elife· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.
Elisa Rossini, Mariangela Tamburello, Andrea Abate, Silvia Zini, Giovanni Ribaudo, Francesca Valcamonico

Cells· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis.
Marco Bergamini, Alberto Dalla Volta, Francesca Valcamonico, Irene Caramella, Martina Buffoni

Case Rep Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients.
Alberto Dalla Volta, Irene Caramella, Pierluigi Di Mauro, Marco Bergamini, Deborah Cosentini, Francesca Valcamonico

Curr Oncol Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib.
Alberto Dalla Volta, Andrea Delbarba, Francesca Valcamonico, Carlo Cappelli, Irene Caramella

In Vivo· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question.
Irene Caramella, Alberto Dalla Volta, Marco Bergamini, Deborah Cosentini, Francesca Valcamonico

Endocrine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Degarelix Administration on Bone Health in Prostate Cancer Patients Without Bone Metastases. The Blade Study.
Carlotta Palumbo, Alberto Dalla Volta, Stefania Zamboni, Gherardo Mazziotti, Manuel Zamparini, Francesca Valcamonico

J Clin Endocrinol Metab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation.
Marco Bergamini, Alberto Dalla Volta, Irene Caramella, Luisa Bercich, Simona Fisogni, Francesca Valcamonico

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?
Irene Caramella, Alberto Dalla Volta, Francesca Valcamonico, Salvatore Grisanti, Alfredo Berruti

Prostate Cancer Prostatic Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study.
Carlotta Palumbo, Alessandro Antonelli, Luca Triggiani, Alberto Dalla Volta, Filippo Maffezzoni, Francesca Valcamonico

Prostate Cancer Prostatic Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Orazio Caffo, Cinzia Ortega, Franco Nolè, Donatello Gasparro, Claudia Mucciarini, Francesca Valcamonico

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance versus discontinuation of androgen deprivation therapy during continuous or intermittent docetaxel administration in castration-resistant prostate cancer patients: A multicentre, randomised Phase III study by the Piemonte Oncology Network.
Susanna Bianchi, Alessandra Mosca, Alberto Dalla Volta, Veronica Prati, Cinzia Ortega, Francesca Valcamonico

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib.
Elisa Rossini, Valentina Bosatta, Andrea Abate, Martina Fragni, Valentina Salvi, Francesca Valcamonico

Clin Genitourin Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
Lilia Bardoscia, Luca Triggiani, Marco Sandri, Simone Francavilla, Paolo Borghetti, Francesca Valcamonico

World J Urol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?
Alberto Dalla Volta, Francesca Valcamonico, Stefania Zamboni, Vittorio D Ferrari, Salvatore Grisanti

Minerva Urol Nefrol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures.
Alberto Dalla Volta, Francesca Valcamonico, Rebecca Pedersini, Carla Fornaro, Valeria Tovazzi

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Less Is More: Specific Capture and Analysis of Tumor Exosomes in Plasma Increases the Sensitivity of Liquid Biopsy for Comprehensive Detection of Multiple Androgen Receptor Phenotypes in Advanced Prostate Cancer Patients.
Chiara Foroni, Natasa Zarovni, Laura Bianciardi, Simona Bernardi, Luca Triggiani, Francesca Valcamonico

Biomedicines· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica" [Crit. Rev. Oncol. Hematol. 137 (2019) (May) 154-164].
Giuseppe Luigi Banna, Nicola Nicolai, Giovannella Palmieri, Margaret Ottaviano, Luca Balzarini, Francesca Valcamonico

Crit Rev Oncol Hematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica.
Giuseppe Luigi Banna, Nicola Nicolai, Giovannella Palmieri, Margaret Ottaviano, Luca Balzarini, Francesca Valcamonico

Crit Rev Oncol Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity.
Francesca Bedussi, Diego Galli, Martina Fragni, Francesca Valcamonico, Elisa Rossini

Pharmacology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Vitamin D and Prostate Cancer Prognosis: The Story Continues.
Elisa Roca, Francesca Valcamonico, Vito Amoroso, Alessandro Antonelli, Chiara Foroni

J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
Alberto Diminutto, Umberto Basso, Marco Maruzzo, Franco Morelli, Ugo De Giorgi, Francesca Valcamonico

Clin Genitourin Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis